[1]付占立,王荣福.能量底物环境对18F-FDG显像的影响[J].国际放射医学核医学杂志,2000,24(2):55-58.
　FU Zhan-li,WANG Rong-fu.The influence of energy substrate environment on 18F-FDG imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(2):55-58.
点击复制

能量底物环境对18F-FDG显像的影响(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
24
期数:
2000年第2期
页码:
55-58
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
The influence of energy substrate environment on 18F-FDG imaging
作者:
付占立;  王荣福
100034 北京, 北京大学第一医院核医学科
Author(s):
FU Zhan-li;  WANG Rong-fu
Department of Nuclear Medicine, The First Hospital of Beijing University, Beijing 100034, China
关键词:
18F-氟代脱氧葡萄糖; 代谢显像; 能量底物环境
Keywords:
18F-fluorodexyglucose; metabolic imaging; energy substrate environment
分类号:
R817.5
摘要:
18F-氟代脱氧葡萄糖(18F-FDG)显像时的体内能量底物环境(血浆葡萄糖、游离脂肪酸等的水平)显著影响肿瘤,心肌及脑等组织对18F-FDG的摄取,从而影响影像质量及临床对影像的分析判断。因此,根据不同的检查目的,合理控制18F-FDG显像时的能量底物环境,是提高影像质量及实现正确影像分析的基础。
Abstract:
The energy substrate environment in body (the level of plasmaglucose and free fat acid et al) during the 18F-FDG imaging significantly affects the uptake of 18F-FDG in the tissues of tumor, myocardium and brain. It will further influence the quality of image, the clinical analysis of the image and the clinical judgement based on the 18F-FDG imaging. So during the 18F-FDG study,reasonably controlling of energy substrate environment according to the clinical study purpose is the basis of improving the quality of image and making correct analysis of the image.

参考文献/References:

[1] O’Doherty MJ. PET in oncology I——lung, breast, soft tissue sarcoma[J]. Nucl Med Commun, 2000, 21:224~229.
[2] Brock CS, Meickle SR, Price P. Dose fluorine-18 fluorodeoxyglucose metabolic imaging of tumor benefit oncology[J]. Eur J Nucl Med, 1997, 24; 691~750.
[3] Tamaki N,Tadamura E,Kudoh T,et al.Recent advances in nuclear cardiology in the study of coronary artery disease[J]. Ann Nucl Med,1997, 11:55~66.
[4] Beanlands R,deKemp R,Smith S,et al.F-18-FDG PET imaging alters clinical decision making in patients with impaired ventricular function[J]. Am J Cardio,1997, 79:1092~1095.
[5] Maes A,Mortelmans L,Nuyts J,et al.Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute mycardial infarction[J]. Eur Heart J,1997, 18:954~962.
[6] Saha GB, MacIntyr WJ, Brunken RC, et al. Present Assessment of Myocardial Viability by Nuclear Imaging[J]. Semin Nucl Med, 1996, 26:315~335.
[7] Bax J, Veening M, Visser F, et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging:a comparative study using different protocols[J]. Eur J Nucl Med, 1997, 24:35~41.
[8] Cremerius U, Bares R, Weis J, et al. Fasting improves discrimination of grading l and atypical or malignant meningioma in FDG-PET[J]. J Nucl Med, 1997, 38:26~30.

相似文献/References:

[1]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):10.
[2]陈香,赵军.PET-CT在非小细胞肺癌中的应用[J].国际放射医学核医学杂志,2005,29(3):97.
　CHEN Xiang,ZHAO Jun.The application value of PET-CT imaging in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):97.
[3]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):197.
[4]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):201.
[5]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):205.
[6]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):209.
[7]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):213.
[8]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):216.
[9]黄建敏,付占立,潘莉萍.18F-FDG代谢显像标准摄取值的影响因素[J].国际放射医学核医学杂志,2004,28(1):3.
　HUANG Jian-min,FU Zhan-li,PAN Li-ping.Affect factors of the standardized uptake value for metabolic imaging with 18F-fluorine-2-deoxy-D-glucose[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(2):3.
[10]董爱生.18F-FDG PET在结直肠癌中的临床应用价值[J].国际放射医学核医学杂志,2004,28(1):12.
　DONG Ai-sheng.The applications of 18F-FDG PET in colorectal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(2):12.

备注/Memo

备注/Memo:
收稿日期:1999-12-05。
基金项目:卫生部科学研究基金资助项目(96-1-289)
作者简介:付占立(1967-),男,河北保定博野人,北京大学第一医院核医学科医师,硕士,主要研究方向:心脏核医学;王荣福(1955-),男,福建南平浦城人,北京大学第一医院核医学科副教授,博士,主要研究方向:神经受体显像、正电子显像。
更新日期/Last Update: 1900-01-01